179 related articles for article (PubMed ID: 29507304)
21. Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up.
Arevalo JF; Wu L; Sanchez JG; Maia M; Saravia MJ; Fernandez CF; Evans T
Eye (Lond); 2009 Jan; 23(1):117-23. PubMed ID: 17891058
[TBL] [Abstract][Full Text] [Related]
22. Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China.
Liu S; Wang D; Chen F; Zhang X
BMC Ophthalmol; 2019 Jul; 19(1):157. PubMed ID: 31337360
[TBL] [Abstract][Full Text] [Related]
23. What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.
Shi L; Yang J; Lin J
BMC Ophthalmol; 2019 Jun; 19(1):128. PubMed ID: 31185956
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal bevacizumab (Avastin) in proliferative diabetic retinopathy.
Minnella AM; Savastano CM; Ziccardi L; Scupola A; Falsini B; Balestrazzi E
Acta Ophthalmol; 2008 Sep; 86(6):683-7. PubMed ID: 17995986
[TBL] [Abstract][Full Text] [Related]
25. Widefield optical coherence tomography angiography for early detection and objective evaluation of proliferative diabetic retinopathy.
Khalid H; Schwartz R; Nicholson L; Huemer J; El-Bradey MH; Sim DA; Patel PJ; Balaskas K; Hamilton RD; Keane PA; Rajendram R
Br J Ophthalmol; 2021 Jan; 105(1):118-123. PubMed ID: 32193221
[TBL] [Abstract][Full Text] [Related]
26. Topographical distribution of retinal and optic disc neovascularization in early stages of proliferative diabetic retinopathy.
Jansson RW; Frøystein T; Krohn J
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8246-52. PubMed ID: 23169887
[TBL] [Abstract][Full Text] [Related]
27. LSFG findings of proliferative diabetic retinopathy after intravitreal injection of bevacizumab.
Enaida H; Okamoto K; Fujii H; Ishibashi T
Ophthalmic Surg Lasers Imaging; 2010 Dec; 41 Online():e1-3. PubMed ID: 22785537
[TBL] [Abstract][Full Text] [Related]
28. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R
Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427
[TBL] [Abstract][Full Text] [Related]
29. TIME COURSE OF CHANGES IN OPTIC DISK NEOVASCULARIZATION AFTER A SINGLE INTRAVITREAL BEVACIZUMAB INJECTION.
Falavarjani KG; Habibi A; Khorasani MA; Anvari P; Sadda SR
Retina; 2019 Jun; 39(6):1149-1153. PubMed ID: 29466258
[TBL] [Abstract][Full Text] [Related]
30. Optical coherence tomography angiography for the detection and evaluation of ptic disc neovascularization: a retrospective, observational study.
Wang XN; Zhou J; Cai X; Li T; Long D; Wu Q
BMC Ophthalmol; 2022 Mar; 22(1):125. PubMed ID: 35296271
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal bevacizumab in inflammatory ocular neovascularization.
Mansour AM; Mackensen F; Arevalo JF; Ziemssen F; Mahendradas P; Mehio-Sibai A; Hrisomalos N; Lai TY; Dodwell D; Chan WM; Ness T; Banker AS; Pai SA; Berrocal MH; Tohme R; Heiligenhaus A; Bashshur ZF; Khairallah M; Salem KM; Hrisomalos FN; Wood MH; Heriot W; Adan A; Kumar A; Lim L; Hall A; Becker M
Am J Ophthalmol; 2008 Sep; 146(3):410-416. PubMed ID: 18619571
[TBL] [Abstract][Full Text] [Related]
32. RETINAL MICROVASCULAR CHANGES IN UVEAL MELANOMA FOLLOWING CONBERCEPT INJECTION AFTER PLAQUE RADIOTHERAPY AS DETECTED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Yang JY; Wang Q; Chen MX; Yan YN; Zhou WJ; Liu YM; Wei WB
Retina; 2021 Dec; 41(12):2605-2611. PubMed ID: 34155168
[TBL] [Abstract][Full Text] [Related]
33. Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab (Avastin).
Isaacs TW; Barry C
Clin Exp Ophthalmol; 2006 Nov; 34(8):802-3. PubMed ID: 17073910
[TBL] [Abstract][Full Text] [Related]
34. Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation.
Messias K; Barroso RM; Jorge R; Messias A
Doc Ophthalmol; 2018 Oct; 137(2):121-129. PubMed ID: 30209775
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal bevacizumab in the treatment of diabetic ocular neovascularization.
Ababneh OH; Yousef YA; Gharaibeh AM; Abu Ameerh MA; Abu-Yaghi NE; Al Bdour MD
Retina; 2013 Apr; 33(4):748-55. PubMed ID: 23296048
[TBL] [Abstract][Full Text] [Related]
36. Morphological differences between optic disc collaterals and neovascularization on optical coherence tomography angiography.
Singh A; Agarwal A; Mahajan S; Karkhur S; Singh R; Bansal R; Dogra MR; Gupta V
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):753-759. PubMed ID: 27942950
[TBL] [Abstract][Full Text] [Related]
37. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.
Ophthalmology; 1993 Nov; 100(11):1655-64. PubMed ID: 8233391
[TBL] [Abstract][Full Text] [Related]
38. Comparison between panretinal photocoagulation and panretinal photocoagulation plus intravitreal bevacizumab in proliferative diabetic retinopathy.
Ahmad M; Jan S
J Ayub Med Coll Abbottabad; 2012; 24(3-4):10-3. PubMed ID: 24669597
[TBL] [Abstract][Full Text] [Related]
39. Objective Evaluation of Proliferative Diabetic Retinopathy Using OCT.
Schwartz R; Khalid H; Sivaprasad S; Nicholson L; Anikina E; Sullivan P; Patel PJ; Balaskas K; Keane PA
Ophthalmol Retina; 2020 Feb; 4(2):164-174. PubMed ID: 31708488
[TBL] [Abstract][Full Text] [Related]
40. Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy.
Bandello F; Polito A; Pognuz DR; Monaco P; Dimastrogiovanni A; Paissios J
Arch Ophthalmol; 2006 May; 124(5):643-50. PubMed ID: 16682585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
